Company Monitoring Page for Amarin

latest headlines for company on cafepharma

Watch Amarin Get Crushed By Wall Street
Seeking Alpha
Fri, 10/12/12 - 12:13 pm
Tags:
Amarin, Vascepa
Amarin Declines as Investors Wait on Drug’s Exclusivity Decision
Bloomberg
Wed, 10/10/12 - 11:51 am
Tags:
Amarin, exclusivity, Vascepa, hypertriglyceridemia
Amarin: The Basics, Pros, Cons, The Whole Scoop
Seeking Alpha
Tue, 10/9/12 - 11:14 am
Tags:
Amarin, Abbott Labs, GSK
Weekend Recap: Biotech Madness
Seeking Alpha
Sun, 10/7/12 - 11:47 am
Tags:
Sarepta Therapeutics, Synta Pharmaceuticals, Arena Pharmaceuticals, Arqule, Amarin, Acadia, Aeterna Zentaris
Insider Sales Case Study: It Is A Deceptive Indicator Of Insider Confidence In A Company
Seeking Alpha
Fri, 10/5/12 - 12:20 pm
Tags:
Amarin
[video]Is Wall Street Turning on Amarin?
Motley Fool
Fri, 10/5/12 - 11:22 am
Tags:
Amarin
3 Interesting Moves In Biotech Stocks From Wednesday
Seeking Alpha
Thu, 10/4/12 - 10:58 am
Tags:
Sarepta, Amarin, Arena Pharmaceuticals, Belviq, Vascepa, eteplirsen
Amarin: A Good Entry Point Ahead Of Major News Next Month
Seeking Alpha
Thu, 09/27/12 - 10:39 am
Tags:
Amarin, Vascepa
Could Amarin Be an Acquisition Target?
Motley Fool
Fri, 09/21/12 - 11:29 am
Tags:
Amarin, M&A, GSK
Should This News Scare Amarin Investors?
Motley Fool
Sat, 09/15/12 - 11:17 am
Tags:
Amarin
Acadia: A Big Move Into Parkinson's Disease Psychosis Results
Seeking Alpha
Wed, 09/12/12 - 11:33 am
Tags:
Acadia, Parkinson's Disease Psychosis, pimavanserin, Amarin
Amarin Sees With 2030 Vision
Motley Fool
Tue, 09/11/12 - 10:43 am
Tags:
Amarin, Vascepa
Why Vascepa's NCE Status Might Still Be Unresolved This Month
Seeking Alpha
Mon, 09/10/12 - 11:19 am
Tags:
NCE, Vascepa, Amarin
Is Amarin Positioned To Be A Takeover Target?
Seeking Alpha
Mon, 09/10/12 - 11:11 am
Tags:
Amarin, M&A
5 BioPharmas To Watch For Wednesday, September 5
Seeking Alpha
Wed, 09/5/12 - 12:46 pm
Tags:
Amarin, GSK, BioSante, NovaBay Pharmaceuticals, Santarus, Sarepta
Amarin issues patent update on fish-oil drug
Marketwatch
Wed, 09/5/12 - 12:37 pm
Tags:
Amarin, patents, fish oil, Vascepa
Four Important Biotech Stocks Targeting Unmet Needs
Motley Fool
Tue, 09/4/12 - 11:08 am
Tags:
Neurocrine Biosciences, Acorda Therapeutics, Amarin, Nektar
Amarin: Update On NCE Status And Patent Protection
Seeking Alpha
Tue, 08/21/12 - 12:03 pm
Tags:
patents, Amarin, Vascepa, GSK, Abbott Laboratories
Amarin Buyout Rumors Gaining Traction?
Seeking Alpha
Sat, 08/11/12 - 12:19 pm
Tags:
Amarin, M&A, Merck, GSK
Amarin's Upcoming Catalysts Should Push Shares Higher
Yahoo/Reuters
Thu, 08/9/12 - 11:55 am
Tags:
Amarin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.